In some settings, susceptible-dose dependent (SDD) categorization is
used: isolates with intermediate MICs may still respond to higher
fluconazole doses, but the presence of ERG11 mutations often reduces the
likelihood of clinical success even with dose escalation. (PMC)
Beyond single substitutions, clinical isolates frequently carry
combinations of ERG11 changes plus efflux-regulatory mutations (e.g.,
TAC1 gain-of-function) that together produce higher MICs and poorer
outcomes; thus, sequencing plus expression data can refine prognostic
interpretation.
Fungi - Candida albicans - Telomere Research Descriptive Posts - Post 6
Techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy can provide detailed information about the binding affinity and structural changes induced by drug binding, guiding the development of more potent and selective inhibitors. Targeting the mutated ERG11 within the nuclear environment, where DNA replication and transcription occur, could offer a strategy to disrupt fungal growth and proliferation.
Comments
Post a Comment